drugset / Trial / NCT07843693
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
Non-randomizedParallel-groupOpen-labelBasic science
Summary
This is a Phase 1, open label, five arm study to evaluate the pharmacodynamic effects of multiple doses of upadacitinib, tofacitinib, and baricitinib in healthy adult participants.
Timeline
- Start
- 2026-08-26
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baricitinib | Small molecule | — | Oral |
| Subject | Tofacitinib | Small molecule | — | Oral |
| Subject | Upadacitinib | Small molecule | — | Oral |
Indications
No indication recorded.